|
ARHGAP17 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.92249999755967E-08 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.65910000182734E-08 |
| Normal-vs-Stage2 |
3.119500E-03 |
| Normal-vs-Stage3 |
7.570400E-04 |
| Normal-vs-Stage4 |
1.637770E-04 |
| Stage1-vs-Stage2 |
5.826200E-01 |
| Stage1-vs-Stage3 |
7.964300E-02 |
| Stage1-vs-Stage4 |
6.545600E-01 |
| Stage2-vs-Stage3 |
5.034800E-01 |
| Stage2-vs-Stage4 |
4.696600E-01 |
| Stage3-vs-Stage4 |
1.064170E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.01160000271139E-08 |
| Normal-vs-AfricanAmerican |
1.357620E-02 |
| Normal-vs-Asian |
9.04750000030319E-07 |
| Caucasian-vs-AfricanAmerican |
7.282200E-01 |
| Caucasian-vs-Asian |
1.797910E-02 |
| AfricanAmerican-vs-Asian |
1.988800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.18010000052615E-08 |
| Normal-vs-Female |
5.15310000004376E-07 |
| Male-vs-Female |
8.366300E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.86289999776812E-09 |
| Normal-vs-Age(41-60Yrs) |
3.90080000001181E-06 |
| Normal-vs-Age(61-80Yrs) |
5.695800E-03 |
| Normal-vs-Age(81-100Yrs) |
9.122400E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.345790E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.982800E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.490400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.144790E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.633800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.049000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.372470E-02 |
| Classical-VS-Follicular |
1.64699999971596E-07 |
| Classical-VS-Other |
1.156640E-01 |
| Classical-VS-Normal |
3.05220293483899E-11 |
| Tall-VS-Follicular |
3.695600E-02 |
| Tall-VS-Other |
3.161400E-01 |
| Tall-VS-Normal |
1.578550E-03 |
| Follicular-VS-Other |
8.899800E-01 |
| Follicular-VS-Normal |
2.725600E-01 |
| Other-VS-Normal |
4.413400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.31189999999804E-05 |
| Normal-vs-N1 |
8.150500E-04 |
| N0-vs-N1 |
3.602000E-01 |
|
|
